Brain MRI in Stroke Patients With Intracardiac Thrombus
Completed
- Conditions
- Intracardiac ThrombusStroke
- Interventions
- Other: No intervention,
- Registration Number
- NCT04456309
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
Acute infarction patterns have been described in cardioembolic stroke, mainly with atrial fibrillation (AF) or patent foramen ovale. We aimed to analyse acute infarction MRI characteristics in stroke patients with intracardiac thrombus (ICT) compared with stroke patients with AF.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
- consecutive patients presenting with acute symptomatic cardioembolic infarction associated with ICT, recruited and registered in the stroke database between June 2018 and November 2019 of our centre (Nîmes University Hospital, France). These patients were compared with consecutive cardioembolic stroke patients with known or newly discovered AF (in the absence of ICT on echocardiography), recruited during the same time period.
- Brain MRI (including diffusion-weighted imaging [DWI]) performed within one week of symptom onset; complete etiological work-up including intracranial (time-of-flight [TOF], gadolinium-enhanced magnetic resonance angiography [MRA], or computed tomographic angiography [CTA]) and extracranial (gadolinium-enhanced MRA, CTA, or duplex ultrasound) vessel imaging; transthoracic or transoesophageal echocardiography; and ≥24h ECG monitoring (acute stroke unit monitoring and/or Holter ECG monitoring).
Exclusion Criteria
- opt-out patient
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Atrial fibrillation No intervention, stroke patients with atrial fibrillation Intracardiac thrombus No intervention, stroke patients with intracardiac thrombus
- Primary Outcome Measures
Name Time Method Brain MRI characteristics Day of inclusion (Day 1) total infarction volume.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU de Nîmes
🇫🇷Nîmes, France